日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk Factors for Empiric Treatment Failure in US Female Outpatients with Uncomplicated Urinary Tract Infection: an Observational Study

美国女性门诊单纯性尿路感染患者经验性治疗失败的危险因素:一项观察性研究

Fromer, Debra L; Luck, Meghan E; Cheng, Wendy Y; Mahendran, Malena; da Costa, Wilson L; Pinaire, Megan; Duh, Mei Sheng; Preib, Madison T; Ellis, Jeffrey J

Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

一线治疗反应欠佳的高危真性红细胞增多症患者改用鲁索替尼治疗与未改用鲁索替尼治疗的临床结局:PV-Switch 研究结果

Koschmieder, Steffen; Schulte, Clemens; von der Heyde, Eyck; Busque, Lambert; Boyer-Perrard, Françoise; Devos, Timothy; Passamonti, Francesco; Cheng, Wendy Y; Cheng, Mu; Nuortti, Marja; Baum, Volker; Harrison, Claire

A pilot evaluation of the artificial intelligence system CAD-EYE to optically characterise lesions in inflammatory bowel disease surveillance

一项针对炎症性肠病监测中病变光学表征的人工智能系统 CAD-EYE 的试点评估

Picardo, Sherman; Menon, Shankar; So, Kenji; Venugopal, Kannan; Cheng, Wendy; Ragunath, Krish

Assessing the burden of outpatient urinary tract infections in the United States: analysis of nationwide ambulatory data (2016-2019)

评估美国门诊泌尿道感染的负担:全国门诊数据分析(2016-2019 年)

Advani, Sonali D; Luck, Meghan E; Chang, Rose; Duh, Mei Sheng; Desai, Raj; Pinaire, Megan; Liu, Daisy; Cheng, Wendy Y; Ellis, Jeffrey J

Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract Infection

开发预测模型以构建大肠杆菌引起的非复杂性尿路感染抗生素耐药性的新型风险分类框架

Shields, Ryan K; Cheng, Wendy Y; Kponee-Shovein, Kalé; Indacochea, Daniel; Gao, Chi; Kuwer, Fernando; Joshi, Ashish V; Mitrani-Gold, Fanny S; Schwab, Patrick; Ferrinho, Diogo; Mahendran, Malena; Pinheiro, Lisa; Royer, Jimmy; Preib, Madison T; Han, Jennifer; Colgan, Richard

Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis

美国阵发性睡眠性血红蛋白尿症患者接受拉武利珠单抗治疗的给药模式:一项基于索赔数据的回顾性分析

Cheng, Wendy Y; Fishman, Jesse; Yenikomshian, Mihran; Mahendran, Malena; Kunzweiler, Colin; Vu, Jensen Duy; Duh, Mei Sheng

Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost

哮喘患者带状疱疹负担:真实世界发病率、医疗资源利用和成本

Singer, David; Thompson-Leduc, Philippe; Ma, Siyu; Gupta, Deepshekhar; Cheng, Wendy Y; Muthukumar, Aruna; Devine, Francesca; Sundar, Manasvi; Bogart, Michael; Hagopian, Ella; Poston, Sara; Duh, Mei Sheng; Oppenheimer, John J

Predictors of survival in autoimmune liver disease overlap syndromes

自身免疫性肝病重叠综合征的生存预测因素

Jayabalan, Dujinthan; Huang, Yi; Calzadilla-Bertot, Luis; Janjua, Malik; de Boer, Bastiaan; Joseph, John; Cheng, Wendy; Hazeldine, Simon; Smith, Briohny W; MacQuillan, Gerry C; Wallace, Michael C; Garas, George; Adams, Leon A; Jeffrey, Gary P

Gastrointestinal manifestations in pediatric and adult patients with Rett syndrome: an analysis of US claims and physician survey data

Rett综合征患儿及成人患者的胃肠道表现:美国医疗保险索赔数据和医生调查数据的分析

May, Damian M; Neul, Jeffrey; Piña-Garza, Jesús Eric; Kponee-Shovein, Kalé; Satija, Ambika; Mahendran, Malena; Downes, Nathaniel; Sheng, Kristy; Lema, Neema; Boca, Andra; Lefebvre, Patrick; Abler, Victor; Youakim, James M; Cheng, Wendy Y

Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study

为激励澳大利亚成年人使用直接抗病毒药物治疗丙型肝炎而提供的经济激励措施(早期丙型肝炎治疗靶向激励措施的系统评估和优化:MOTIVATE-C):一项剂量反应随机对照研究方案

Fathima, Parveen; Jones, Mark; D'Souza, Reena; Totterdell, James; Andric, Nada; Abbott, Penelope; Norman, Richard; Howard, Kirsten; Cheng, Wendy; Pedrana, Alisa; Doyle, Joseph S; Davies, Jane; Snelling, Thomas